Loading…
Restore Protections for Dialysis Patients Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,357 other S bills in the 117th — cohort avg 38d
Restore Protections for Dialysis Patients Act This bill specifies that private health insurers may not limit, restrict, or condition benefits for renal dialysis services for individuals with end-stage renal disease as compared to other types of benefits for other medical conditions under Medicare secondary payer rules.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Read twice and referred to the Committee on Finance.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2026 · third_quarter · Health Issues
Meetings with minority staff of House Ways and Means in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. Meeting with the Senate HELP Committee to talk about Large Dialysis Providers duopoly and learn more about Senate oversight of this industry. Meeting with House and Senate Democratic Offices, Ways and Means Committee, minority staff of House Energy and Commerce Committee, and minority staff of Senate Finance to discuss GOP Waste, Fraud and Abuse Narrative to scale back Medicaid HCBS. Prepped SEIU Members and supported Congressional Progressive Caucus (CPC) Shadow Hearing on lowering healthcare costs. Meeting with Rep. Simon aide Addy Rosales to discuss SEIU healthcare and childcare priorities. Meeting with office of Rep. McBride to support investments in homecare, childcare and importance of 6 weeks of paid family and medical leave. Participated in Prep Call organized by Office of Minority Leader to discuss stakeholders and SEIU healthcare priorities which include repealing cuts to Medicaid, protecting the ACA and supporting our Care infrastructure and workers in the US. Multiple meetings with Rep. Barragans legislative staff to discuss support for homecare and defending attacks that could impact care for vulnerable people and workforce. Meeting with Rep. Tonko legislative aide to discuss support for homecare and defending attacks that could impact care for vulnerable people and workforce. Group Meeting organized by AFL-CIO and Senate Minority health staff to discuss IDR and No Surprise Act.
Client expense: $310,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Meetings with minority staff of House Ways and Means, House Energy and Commerce, Senate Finance Committees and health staff for Rep. Hakeem Jeffries and Sen. Chuck Schumer in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. SEIU also sent a note to all Members in the House and Senate in strong opposition to this legislation. Follow up Meeting on Union endorsement of a Senate Resolution introduced by Senators Wyden, Markey, King in support of expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a proposed reduction in public notice and comment opportunities; and subsequent conversations with Senate Offices urging their cosponsorship of CRA resolution of disapproval to reverse the Richard Waiver. Met with staff of Rep. Debbie Dingell, and supported introduction of H.R. 5228, HCBS Workers Protection Act of 2025. Meeting with House and Senate Dem Offices expressing concerns about HHS Reorganization and RFKs Jr. Leadership of HHS. Introduction Meeting with Minority Staff of Senate Committee on Aging and Health and Labor Staff for Senator Gillibrand. SEIU had no specific request during this meeting, and recapped our past work with the Committee in previous Congresses. Meetings and SEIUs endorsement of a Congressional Review (CRA) Act bill to repeal the ACA Marketplace Integrity and Affordability Final Rule introduced by Rep. Sykes (D-OH) and Senator Warner (D-VA). Consultation with Senate HELP Senior Health Policy Advisor Michaela Brown on introduction of Sen. Sanders Health Care Workforce Expansion Act.
Client expense: $260,000 · Firm income: Not reported
2025 · fourth_quarter · Health Issues
Meetings with minority staff of House Ways and Means, House Energy and Commerce, Senate Finance Committees and health staff for Rep. Hakeem Jeffries and Sen. Chuck Schumer in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. Also assisted, escorted and advocated with SEIU Members organized with United Healthcare Workers West in opposition to this legislation during their advocacy fly in on November 18th and 19th where they spoke to House and Senate Members. Follow up Meetings and advocacy email to all Senate Dems in support of Union endorsement of a Senate Resolution and CRA legislation introduced by Senators Wyden, Markey, King in support of expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a proposed reduction in public notice and comment opportunities; and subsequent conversations with Senate Offices urging their co-sponsorship of CRA resolution of disapproval to reverse the Richard Waiver. Consultation with staff of Rep. Debbie Dingell, and supported introduction of H.R. 5228, HCBS Workers Protection Act of 2025 and revisions as they draft HCBS Access Act in 119th Congress. Lobbying for an extension of the ACA premium tax credits in H.R. 1834 and additional vehicles.
Client expense: $255,000 · Firm income: Not reported
2025 · fourth_quarter · Health Issues
Meetings with minority staff of House Ways and Means, House Energy and Commerce, Senate Finance Committees and health staff for Rep. Hakeem Jeffries and Sen. Chuck Schumer in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. Also assisted, escorted and advocated with SEIU Members organized with United Healthcare Workers West in opposition to this legislation during their advocacy fly in on November 18th and 19th where they spoke to House and Senate Members. Follow up Meetings and advocacy email to all Senate Dems in support of Union endorsement of a Senate Resolution and CRA legislation introduced by Senators Wyden, Markey, King in support of expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a proposed reduction in public notice and comment opportunities; and subsequent conversations with Senate Offices urging their co-sponsorship of CRA resolution of disapproval to reverse the Richard Waiver. Consultation with staff of Rep. Debbie Dingell, and supported introduction of H.R. 5228, HCBS Workers Protection Act of 2025 and revisions as they draft HCBS Access Act in 119th Congress. Lobbying for an extension of the ACA premium tax credits in H.R. 1834 and additional vehicles.
Client expense: $215,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Meetings with minority staff of House Ways and Means, House Energy and Commerce, Senate Finance Committees and health staff for Rep. Hakeem Jeffries and Sen. Chuck Schumer in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. SEIU also sent a note to all Members in the House and Senate in strong opposition to this legislation. Follow up Meeting on Union endorsement of a Senate Resolution introduced by Senators Wyden, Markey, King in support of expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a proposed reduction in public notice and comment opportunities; and subsequent conversations with Senate Offices urging their cosponsorship of CRA resolution of disapproval to reverse the Richard Waiver. Met with staff of Rep. Debbie Dingell, and supported introduction of H.R. 5228, HCBS Workers Protection Act of 2025. Meeting with House and Senate Dem Offices expressing concerns about HHS Reorganization and RFKs Jr. Leadership of HHS. Introduction Meeting with Minority Staff of Senate Committee on Aging and Health and Labor Staff for Senator Gillibrand. SEIU had no specific request during this meeting, and recapped our past work with the Committee in previous Congresses. Meetings and SEIUs endorsement of a Congressional Review (CRA) Act bill to repeal the ACA Marketplace Integrity and Affordability Final Rule introduced by Rep. Sykes (D-OH) and Senator Warner (D-VA). Consultation with Senate HELP Senior Health Policy Advisor Michaela Brown on introduction of Sen. Sanders Health Care Workforce Expansion Act.
Client expense: $223,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Meetings with minority staff of House Ways and Means, House Energy and Commerce, Senate Finance Committees and health staff for Rep. Hakeem Jeffries and Sen. Chuck Schumer in opposition to H.R. 2199/S. 4750, the Restore Protections for Dialysis Patients Act. SEIU also sent a note to all Members in the House and Senate in strong opposition to this legislation. Follow up Meeting on Union endorsement of a Senate Resolution introduced by Senators Wyden, Markey, King in support of expressing the sense of the Senate that the Secretary of Health and Human Services should withdraw a proposed reduction in public notice and comment opportunities; and subsequent conversations with Senate Offices urging their cosponsorship of CRA resolution of disapproval to reverse the Richard Waiver. Met with staff of Rep. Debbie Dingell, and supported introduction of H.R. 5228, HCBS Workers Protection Act of 2025. Meeting with House and Senate Dem Offices expressing concerns about HHS Reorganization and RFKs Jr. Leadership of HHS. Introduction Meeting with Minority Staff of Senate Committee on Aging and Health and Labor Staff for Senator Gillibrand. SEIU had no specific request during this meeting, and recapped our past work with the Committee in previous Congresses. Meetings and SEIUs endorsement of a Congressional Review (CRA) Act bill to repeal the ACA Marketplace Integrity and Affordability Final Rule introduced by Rep. Sykes (D-OH) and Senator Warner (D-VA). Consultation with Senate HELP Senior Health Policy Advisor Michaela Brown on introduction of Sen. Sanders Health Care Workforce Expansion Act.
Client expense: $210,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $90,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2025 · first_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $90,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program. Oral drug reimbursement.
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · third_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program.
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Health Issues
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session; H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Medicare/Medicaid
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session; H.R. 5027, Chronic Kidney Disease Improvement in Research and Training Act; CMS 1782, CY 2024 Changes to the End-Stage Renal Disease (ESRD) Prospective Payment Systems (PPS) and Quality Incentive Program (QIP) proposed rule
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · third_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · third_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Medicaid same-day billing; provider directories; RADV Rule and Rate Notice; Medicare Advantage Advance Rate Notice and Prior Authorization legislation; Medicaid Redeterminations; Medicaid work requirements; IRA implementation S 4750 Restore Protections for Dialysis Patients Act - To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act
Client expense: $790,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
Medicaid same-day billing; Provider Directories; RADV Rule & Rate Notice; Medicare Advantage Advance Rate Notice and Prior Authorization Legislation; Medicaid Redeterminations; Medicare Wage Index Proposal; Draft Duals legislation; Medicaid work requirements; IRA Implementation S.1038/H.R.1613 - Drug Price Transparency in Medicaid Act of 2023 Sponsor: Sen. Welch, Peter [D-VT]; Sponsor: Rep. Carter, Earl L. "Buddy" [R-GA-1] - To amend title XIX of the Social Security Act to improve transparency and prevent the use of abusive spread pricing and related practices in the Medicaid program. S.4750 - Restore Protections for Dialysis Patients Act To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act. Sponsor: Sen. Menendez, Robert [D-NJ]
Client expense: $1,580,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2023 · second_quarter · Medicare/Medicaid
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · second_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $100,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Medicare/Medicaid
CKCC Model. Dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · first_quarter · Medicare/Medicaid
Issues relating to S. 4750/H.R. 8594, the Restoring Protections for Dialysis Patients Act, from the 117th Congress, 2d Session
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2023 · first_quarter · Health Issues
Provide guidance, and strategic counsel on federal regulatory policy and legislative issues affecting the quality of kidney care and treatment including the ESRD Prospective Payment System Regulation and the Chronic Kidney Disease Improvement in Research and Treatment Act, Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750) and other bills impacting kidney care.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Health Issues
S. 4750 - Restore Protections for Dialysis Patients Act, provisions related to commercial health coverage (117th Congress); S. 3018/H.R. 3173 - Improving Seniors Timely Access to Care Act of 2021, provisions related to Medicare Advantage (117th Congress); Issues related to veterans care coordination, health equity, COVID transition, and the public health emergency. Issues covered: -End of Public Health Emergency - Transition to Commercialization -Medicaid Redeterminations - Access to Coverage -Medicare Advantage - Regulatory Actions -TRICARE -The VA - Veterans Health Care -Prescription Drug Pricing / Pharmacy Benefit Management
Client expense: $220,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2023 · first_quarter · Medicare/Medicaid
CKCC Model: kidney care choices model; dialysis reimbursement issues. S. 4750 / H.R. 8594, Restore Protections for Dialysis Patients Act, issues related to the Medicare Secondary Payer program. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023.
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to Medicare payment for End Stage Renal Disease (ESRD) H.R.8594 / S.4750 (Restore Protections for Dialysis Patients Act)
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
H.R. 8594/S. 4750, the Restore Protections for Dialysis Patients Act H.R. 7845/ the NIH Clinical Trial Diversity Act H.R. 1255/S. 377, the Living Donor Protection Act H.R. 1676, the Jack Reynold Medigap Expansion Act H.R. 526, Ensuring Coverage in Public Health Emergencies Act of 2021 Health disparities S. 1002, the Junk Plan Accountability and Disclosure Act of 2021 H.R. 4065/S. 1971, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2021. H.R. 3893, the CARE for All Kidneys Act FY 2023, Labor-HHS-Education Appropriations Act H.R. 7585, the Health Equity and Accountability Act of 2022 (HEAA) H.R. 5801, the Help Ensure Lower Patient (HELP) Copays Act H.R. 7667, the Food and Drug Amendments of 2022 H.R. 7506, the New Era for Preventing End-Stage Kidney Disease Act of 2022 Medicare Program; Implementing Certain Provisions of the Consolidated Appropriations Act, 2021 and Other Revisions to Medicare Enrollment and Eligibility Rules Diversity Plans To Improve Enrollment of Participants From Underrepresented Racial and Ethnic Populations in Clinical Trials; Draft Guidance for Industry Request for Information on ways to strengthen and improve the Organ Procurement and Transplantation Network
Client expense: $160,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues relating to ESRD policies and reimbursement. H.R. 4942 - The BETTER Kidney Act S. 2649 - The BETTER Kidney Act H.R. 8594 - Restore Protections for Dialysis Patients Act S. 4750 - Restore Protections for Dialysis Patients Act H.R. 1676 - The Jack Reynolds Memorial Medigap Expansion Act
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
General issues related to the Restore Protections for Dialysis Patients Act (H.R. 8594/S. 4750).
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Health Issues
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to home dialysis Issues related to chronic kidney disease (CKD) and prevention Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 S. 368, Telehealth Modernization Act, all provisions MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $960,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues related to End Stage Renal Disease Perspective Payment System HR 7878/S 4307, Kidney Health Connect Act (all provisions) Issues related to supply chain Issues related to end stage renal disease calcimimetics utilization Issues related to Transitional Add-on Payment Adjustment for New and Innovative Equipment and Supplies (TPNIES) Issues related to Transitional Drug Add-on Payment Adjustment (TDAPA) Issues related to nursing shortages H.R. 4942/S. 2649, Bringing Enhanced Treatments and Therapies to ESRD Recipients Kidney Care Act H.R. 1676, The Jack Reynolds Memorial Medigap Expansion Act H.R. 5426, Improving Access to Home Dialysis Act of 2021 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act H.R. 8063, Repair Abuses of MSP Payments Act CMS regulations pertaining to reimbursement rates for ESRD-related services CMS regulations pertaining to the Medicare Advantage program Protection of third party premium assistance for coverage under the Patient Protection and Affordable Care Act Issues related to chronic kidney disease (CKD) and prevention Issues related to home dialysis Issues related to access to kidney transplantation for ESRD patients ESRD Treatment Choices (ETC) mandatory demonstration Kidney Care Choices (KCC) Model and the Comprehensive Kidney Care Contracting (CKCC) voluntary payment options Emergency response related to COVID-19 MedPAC CY22 report to Congress, Medicare end-stage renal disease perspective payment system base rate recommendation S. 1971/ H.R. 4065 Chronic Kidney Disease Improvement in Research and Treatment Act, all provisions ESRD facilities serving as originating sites for telehealth services under the Medicare program H.R. 8295 Fiscal Year 2023 Labor, Health and Human Services, Education, and Related Agencies (LHHS) Appropriations bill, provision relating to KidneyX funding H.R. 6000, CURES 2.0 Act, provisions related to dialysis
Client expense: $960,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2022 · fourth_quarter · Health Issues
Draft, Hospital Competition Act of 2021 (no bill number) - procedural changes around The Mental Health Parity and Addiction Equity Act (MHPEA) litigation H.R. 19 - Lower Costs, More Cures Act of 2021- Rep. McMorris, Rodgers - prescription drug prices for Medicare and Medicaid H.R. 340 - Incentivizing Medicaid Expansion Act of 2021 - Rep. Veasey, Marc - Medicaid expansion H.R. 379 - Improving Social Determinants of Health Act of 2021 - Rep. Barragan, Nanette Diaz - Social Determinants of Health H.R. 432 - Mental Health Access Improvement Act of 2021- Rep. Thompson, Mike - mental health services under Medicare H.R. 778 - Secure Data and Privacy for Contact Tracing Act of 2021 - Rep. Speier, Jackie - digital contact tracing for COVID-19 H.R. 908 - MORE Health Education Act - Rep. Blunt Rochester, Lisa - federally facilitated exchanges H.R. 909 - Moms Matter Act - Rep. Blunt Rochester, Lisa - maternal mental health conditions and SUD H.R. 943 - Social Determinants for Moms Act - Rep. McBath, Lucy -SDOH and maternal health H.R. 959 - Black Maternal Health Momnibus Act of 2021 - Rep. Underwood, Lauren - maternal health including in Medicaid and CHIP H.R. 1212 - Kira Johnson Act - Rep. Adams, Alma - maternal health outcomes H.R. 1218 - Data Mapping to Save Moms Lives Act - Rep. Butterfield, G. K. -maternal health data H.R. 1268 - Building COVID-19 Vaccine Confidence Act of 2021 - Rep. Velazquez, Nydia - COVID-19 H.R. 1319 - American Rescue Plan Act of 2021 - Rep. Yarmuth, John - COVID-19 relief H.R. 1350 - Supporting Best Practices for Healthy Moms Act - Rep. Kelly, Robin - maternal health outcomes H.R. 1364 - Parity Enforcement Act of 2021 - Rep. Norcross, Donald - mental health and SUD H.R. 1400 - COVID-19 Health Disparities Action Act of 2021 - Rep. Cardenas, Tony -COVID-19 and health disparities H.R. 1406 - COVID-19 Emergency Telehealth Impact Reporting Act of 2021 - Rep. Curtis, John - telehealth and COVID-19 H.R. 1544 - Virtual Community Support Act of 2021 - Rep. Cardenas, Tony - mental health and SUD grants for community peer support H.R. 1647 - TREATS Act - Rep. McKinley, David - increase use of telehealth for SUD treatment H.R. 1721 - To amend the Consolidated Appropriations Act, 2021 to authorize additional funds for the Emergency Broadband Connectivity Fund, to provide grants to States and Tribal Entities to strengthen the National Lifeline Eligibility Verifier, to provide for Federal coordination between the National Lifeline Eligibility Verifier and the National Accuracy Clearinghouse - Rep. Veasey, Marc - Broadband H.R. 1835 - COVID Community Care Act - Rep. Lee, Barbara - COVID-19 response H.R. 1848 - LIFT America Act - Rep. Pallone, Frank, Jr. - broadband and public health infrastructure H.R. 1872 - MORE Health Education Act - Rep. Blunt Rochester, Lisa - Federal Exchange outreach and educational activities H.R. 1976 - Medicare for All Act of 2021 - Rep. Jayapal, Pramila - public option H.R. 1985 - Nursing Home Reform Modernization Act of 2021 - Rep. Pascrell, Bill, Jr. - quality and transparency H.R. 2010 - Public Option Deficit Reduction Act- Rep. DeFazio, Peter - public option H.R. 2163 - Safe Step Act - Rep. Ruiz, Raul - commercial plans and medication step-therapy requirements H.R. 2617 - Consolidated Appropriations Act, 2023 - Rep. Connolly, Gerald - continued Medicaid and Medicare provisions and funding for FY2023 H.R. 3173 - Improving Seniors Timely Access to Care Act of 2021 - Rep. DelBene, Suzan - prior authorization in Medicare Advantage H.R. 3753 - Parity Implementation Assistance Act - Rep. Cardenas, Tony - mental health parity H.R. 4040 - Advancing Telehealth Beyond COVID-19 Act of 2021- Rep. Cheney, Liz - telehealth H.R. 4595 - Medicaid Saves Lives Act - Rep. Bourdeaux, Carolyn - Medicaid expansion H.R. 6833 - Continuing Appropriations and Ukraine Supplemental Appropriations Act, 2023 - Rep. Craig, Angie - continued funding for Medicare and Medicaid H.R. 7236 - Strengthen Kids Mental Health Now Act of 2022 - Rep. Eshoo, Anna - mental health and Medicaid H.R. 7427 - To amend title XI of the Social Security Act to require CMI testing of incentive payments for behavioral health providers and certain other providers for adoption and use of certified electronic health record technology, and for other purposes. - Rep. Matsui, Doris - behavioral health and electronic health records H.R. 7512 - Protecting Patients from Deceptive Health Plans Act - Rep. Hayes, Jahana - excepted benefits coverage H.R. 7666 - Restoring Hope for Mental Health and Well-Being Act of 2022 - Rep. Pallone, Frank - reauthorization of several behavioral health programs H.R. 7667 - Food and Drug Amendments of 2022 - Rep. Eshoo, Anna - reauthorization of user fee programs H.R. 7780 - Mental Health Matters Act - Rep. DeSaulnier, Mark - changes to the procedure around MHPEA litigation H.R. 8152 - American Data Privacy and Protection Act - Rep. Pallone, Frank, Jr. - data privacy H.R. 8594 - Restore Protections for Dialysis Patients Act - Rep. Clarke, Yvette - reform of the Medicare Secondary Payer act H.R. 8876 - The Jackie Walorski Maternal and Child Home Visiting Reauthorization Act of 2022 - Rep. Davis, Danny - funding for maternal and early childhood health programs H.R. 8878 - To amend title XVIII of the Social Security Act to ensure adequate coverage of outpatient mental health services under the Medicare program. - Rep. Chu, Judy - mental health and Medicare H.R. 8879 - Inpatient Psychiatric Facility Improvement Act - Rep. Evans, Dwight - mental health and Medicare H.R. 8881 - To amend the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Code of 1986 to require group health plans and health insurance issuers offering group or individual health insurance coverage to disclose the percentage of in-network participation for certain provider types, and for other purposes. - Rep. Horsford, Steven - commercial plans H.R. 8884 - To direct the Secretary of Health and Human Services to provide outreach and reporting on opioid use disorder treatment services furnished by opioid treatment programs under the Medicare program. - Rep. Kelly Mike - mental health and Medicare H.R. 8885 - Better Health Care Directories Act - Rep. Kildee, Daniel - commercial plans H.R. 8886 - Promoting Clarity in Mental Health and Substance Use Disorder Treatment Act - Rep. Moore, Gwen - commercial plans H.R. 8889 - RICE Act - Rep. Plaskett, Stacey - commercial plans H.R. 8890 - Physician Wellness Program Act of 2022 - Rep. Ruiz, Raul - mental health and Medicare H.R. 8891 - No Surprises for Survivors Act of 2022 - Rep. Sanchez, Linda - requirements for group health plans and health insurance issuers offering group or individual health insurance coverage to provide coverage for forensic medical exams with no cost sharing H.R. 8892 - To direct the Secretary of Health and Human Services to conduct a public outreach campaign to inform individuals covered under a group health plan or group or individual health insurance coverage of Federal requirements relating to mental health and substance use disorder crisis services, and for other purposes. - Rep. Sewell, Terri - commercial plans H.R. 8908 - Fighting Stimulant and other Substance Use Disorders Act - Rep. Estes, Ron - mental health and Medicare H.R. 8910 - Behavioral Health Integration Awareness Act of 2022 - Rep. Smith, Jason - mental health and Medicare S. 24 - Protecting Personal Health Data Act - Sen. Klobuchar, Amy - privacy S. 104 - Improving Social Determinants of Health Act of 2021- Sen. Smith, Tina - health disparities S. 199 - Secure Data and Privacy for Contact Tracing Act of 2021 - Sen. Schatz, Brian - digital contact tracing for COVID-19 S. 201 - Improving Access to Health Care in Rural and Underserved Areas Act - Sen. Rosen, Jacky - rural health S. 334 - IMPACT to Save Moms Act - Sen. Casey, Robert - maternal health S. 340 - TREATS Act - Sen. Portman, Rob - telehealth, SUD and mental health S. 345 - Maternal Vaccinations Act - Sen. Kaine, Tim - maternal health S. 346 - Black Maternal Health Momnibus Act of 2021 - Sen. Booker, Cory - maternal health and health disparities S. 347 - Data to Save Moms Act - Sen. Smith, Tina - maternal health data S. 352 - Health Care Improvement Act of 2021 - Sen. Warner, Mark - health care costs and coverage S. 408 - Supporting Best Practices for Healthy Moms Act - Sen. Toomey, Pat - maternal health S. 411 - MOMMAs Act - Sen. Durbin, Richard - maternal health S. 464 - Safe Step Act - Sen. Murkowski, Lisa - commercial plans and medication step-therapy requirements S. 512 - Equitable Data Collection and Disclosure on COVID-19 Act of 2021- Sen. Warren, Elizabeth - COVID-19 Data Collection S. 586 - NOPAIN Act - Sen. Capito, Shelley Moore - non-opioid treatment S. 674 - Public Health Infrastructure Saves Lives Act- Sen. Murray, Patty - public health infrastructure S. 708 - Preventing Mental Health and Substance Use Crises During Emergencies Act - Sen. Kelly, Mark - mental health and SUD national strategy S. 745 - Accessible, Affordable Internet for All Act - Sen. Klobuchar, Amy - broadband S. 779 - Protecting Americans with Pre-Existing Conditions Act of 2021- Sen. Warner, Mark R. - state innovation waivers S. 782 - Nursing Home Reform Modernization Act of 2021- Sen. Casey, Robert P., Jr. - nursing home quality and transparency S. 783 - COVID Community Care Act - Sen. Warren, Elizabeth - COVID-19 response S. 851 - Social Determinants for Moms Act- Sen. Blumenthal, Richard - SDOH and maternal health S. 893 - Tech to Save Moms Act- Sen. Menendez, Robert - maternal health S. 983 - CHOICE Act - Sen. Whitehouse, Sheldon - public option S. 987 - TREATS Act - Sen. Portman, Rob - SUD prevention and treatment S. 1010 - Turn the Tide Act - Sen. Shaheen, Jeanne - Substance Use Disorder S. 1042 - Kira Johnson Act - Sen. Warnock, Raphael - maternal health S. 1512 - CONNECT for Health Act of 2021 - Sen. Schatz, Brian - expansion of telehealth for Medicare S. 1873 - Medicare Multi-Cancer Early Detection Screening Coverage Act of 2021 - Sen. Crapo, Mike - Cancer screening in Medicare S. 1962 - Parity Implementation Assistance Act - Sen. Murphy, Christopher - mental health parity S. 2164 - Lower Costs, More Cures Act of 2021 - Sen. Crapo, Mike - prescription drug prices for Medicare and Medicaid S. 2315 - Medicaid Saves Lives Act - Sen. Warnock, Raphael - Medicaid expansion S. 2499 - SAFE DATA Act - Sen. Wicker, Roger - consumer data privacy and data transparency and security S. 3018 - Improving Seniors Timely Access to Care Act of 2021 - Sen. Marshall, Roger - prior authorization in Medicare Advantage S. 3195 - Consumer Online Privacy Rights Act - Sen. Cantwell, Maria - data privacy S. 3799 - Prevent Pandemics Act - Sen. Murray, Patty - pandemic preparedness S. 3983 - PATCH Act - Sen. Cassidy, Bill - data privacy S. 4264 - Advancing Integration in Medicare and Medicaid (AIM) Act - Sen. Scott, Tim - coordinating full-benefits for dual eligible individuals S. 4293 - Pharmacy Benefit Manager Transparency Act of 2022 - Sen. Cantwell, Maria and Sen. Grassley, Chuck - scope of PBM practices S. 4306 - Improving Access to Behavioral Health Integration Act - Sen. Smith, Tina - behavioral health S. 4750 - Restore Protections for Dialysis Patients Act - Sen. Menendez, Robert - reform of MSP Regulatory Issues: HIPAA administrative simplification issues, including standards for privacy, security, and electronic transactions and code sets (including ICD-10), identifiers, enforcement; cybersecurity; issues related to Medicare Secondary Payer requirements; issues related to health care price transparency; issues related to all payor claims databases; issues related to implementation of the National Health Information Infrastructure; electronic health records, personal health records, and similar technologies; issues relating to market consolidation; issues related to hospital and provider consolidation; issues related to medical management; issues relating to quality improvement; issues relating to the national health data stewardship; issues relating to hospital outpatient measurement and reporting; issues relating to COVID-19, including testing, vaccines and therapeutics; issues related to the end of the public health emergency; issues related to health equity; issues related to vaccination; issues related to addressing the social determinants of health, including housing, transportation, nutrition, and educational opportunities; prescription drug pricing; telehealth; issues related to the cost of insulin, including price, copays, rebates, and medical management tools; rural health; issues related to behavioral health benefits; issues related to Managed Long Term Services and Supports (MLTSS); issues related to the collection of race and ethnicity data; issues related to medical loss ratios; reference pricing; review of rates for reasonableness; preexisting condition insurance plans; issues relating to antitrust; issues relating to surprise medical bills; accountable care organizations; provider non-discrimination; coverage of preventive services; contraceptive coverage and reproductive health; pre-existing condition exclusions; lifetime and annual dollar limits on benefits; patient protections; grandfathered health plan provisions; issues related to health insurance tax; health plan automatic enrollment requirements; issues related to qualified health plans including certification and rate filing templates; health insurance market rules; ACA risk adjustment; dependent coverage; summary of benefits and coverage disclosures; benefit and payment parameters; essential health benefits, actuarial value, and accreditation; NQF reauthorization; issues related to fraud, waste, abuse, Stark/Anti-Kickback laws and regulations; issues related to supplemental products; issues related to HIPAA excepted benefits; issues related to short term limited duration products; issues related to the federally-facilitated marketplaces (i.e., Exchanges/formerly referred to as the web portal); issues related to business continuity in relation to pandemics or natural events (e.g., hurricane, tornado, etc.); issues related to association health plans; issues related to cost-sharing reductions (CSRs); issues related to the refundable credit for coverage under a qualified health plan and enhancements included in the American Rescue Plan Act (ARPA); issues related to Medicaid coverage gap; issues related to small employer group size; issues related to Certificate of Public Advantage; issues relating to veterans health care; issues relating to caregivers; and other issues relating to health care reform implementation.
Client expense: $2,470,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), Office of Management & Budget (OMB), SENATE, Treasury, Dept of, White House Office
- ACO-REACH program (efficacy of recent reforms) - Safety incentive programs (Informed about issues with safety incentive programs) - Surprise bill (role of the qualified payment amount) - nursing home reform initiative (health equity, nurse staffing) - 1115 waivers (proposal for guardrails in state 1115 proposals) - COVID health care protections (Urging the COVID health care standard to be issued; worker health and safety) - Toxic Substance Control Act - Methylene chloride (Urging a strong protective standard for workers; worker health and safety) - H.R. 2617 - Consolidated Appropriations Act, 2023 (Medicaid funding for the territories; dialysis payment rules) - S. 4750 - Restore Protections for Dialysis Patients Act (Requirements for health plan coverage of dialysis services) -
Client expense: $520,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
2022 · fourth_quarter · Health Issues
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act H.R. 1319, American Rescue Plan Act of 2021 H.R. 1976, Medicare for All Act of 2021 H.R. 2471, Consolidated Appropriations Act, 2022 H.R. 2873, Affordable Prescriptions for Patients Through Promoting Competition Act of 2021 H.R. 2884, Affordable Prescriptions for Patients Through Improvements to Patent Litigation Act H.R. 2891, Preserve Access to Affordable Generics and Biosimilars Act H.R. 3114, Longshore and Harbor Workers COVID-19 Compensation Act of 2021 H.R. 4502, Labor, Health and Human Services, Education, Agriculture, Rural Development, Energy and Water Development, Financial Services and General Government, Interior, Environment, Military Construction, Veterans Affairs, Transportation, and Housing and Urban Development Appropriations Act, 2022 H.R. 5981/S.1704, Telehealth Expansion Act of 2021 H.R. 8295, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 H.R. 8594/S. 4750, Restore Protections for Dialysis Patients Act S. 150, Ensuring Parity in Medicare Advantage for Audio-Only Telehealth Act S. 380, Health Savings Act of 2021 S. 1428, Preserve Access to Affordable Generics and Biosimilars Act S. 1435, Affordable Prescriptions for Patients Act of 2021 Implementation of the Transparency in Coverage Final Rule; Internal Revenue Service, Department of the Treasury; Employee Benefits Security Administration, Department of Labor; Centers for Medicare & Medicaid Services, Department of Health and Human Services (85 Fed. Reg. 72,158 - 72,310, November 12, 2020) Requirements Related to Surprise Billing; Internal Revenue Service; Employee Benefits Security Administration; Department of Health and Human Services (87 Fed. Reg. 52,618-52,655, August 26, 2022) Request for Information, Centers for Medicare & Medicaid Services; Medicare Program (87 Fed. Reg. 46,918-46,921, August 1, 2022) Notice of Proposed Rule, Employee Benefits Security Administration; Proposed Amendment to Prohibited Transaction Class Exemption 84-14 (the QPAM Exemption (87 Fed. Reg. 45,204-45,232, July 27, 2022) Affordability of Employer Coverage for Family Members of Employees (Family Glitch Regulation) (87 Fed. Reg. 20,354-20,364, April 7, 2022) Various issues relating to the employer-sponsored health care system, the "family glitch", implementation of regulatory process, provider network adequacy, health savings account (HSAs), health reimbursement account (HRAs), employer mandate; coronavirus pandemic; vaccine distribution, PPE, testing, medications and treatments, and vaccination incentives; digital health credentials; vaccine diplomacy; COVID-19 vaccine requirements, including a potential Emergency Temporary Standard from the Occupational Safety and Health Administration relating to employers with more than 100 employees; vaccine requirements for federal contractors; Executive Order 14042, Ensuring Adequate COVID Safety Protocols for Federal Contractors; implementation of the American Rescue Plan Act (P.L. 117-2); balance or surprise billing and related issues; single-payer health care options; health reimbursement arrangements and other account-based group health plans; Health and Human Services international pricing index (IPI) model; mental health parity; drug pricing; COBRA subsidies; Federal Trade Commissions multilateral pharmaceutical merger taskforce; telehealth, including coverage of telehealth under High Deductible Health Plans (HDHPs) and expanding telehealth options for employees; impact of Pharmacy Benefit Managers Practices; FTC-2022-0015; petition to HHS to grant march-in rights for the patents on the drug Xtandi; comments on COVID-19 Telehealth Program Application Evaluation Metrics (WC Docket No. 20-89); efforts to reform the World Health Organizations (WHO) engagement with private sector; continued U.S. membership to the World Health Organization (WHO); support for necessary market conditions to incentivize health sector investment from private sector; support for private sector involvement in health systems strengthening; greater harmonization of standards and investment in digital health internationally; role of private sector related pandemic prevention, preparedness and response
Client expense: $20,990,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), SENATE, State, Dept of (DOS), U.S. Agency for International Development (USAID), U.S. Trade & Development Agency (USTDA), U.S. Trade Representative (USTR)
2022 · fourth_quarter · Medicare/Medicaid
Medicare; Medicare Advantage; Medicaid; Medicaid postpartum coverage; Medicare Advantage provider directories; Medicaid MOE; Puerto Rico Medicaid Funding; Consumer Assistance Program; Part D; Center for Medicaid and CHIP Services; Part D changes under IRA; Addressing Health-Related Social Needs and SDOH in Medicaid; Medicare Advantage Prior Authorization; H.R. 3173 - Improving Seniors Timely Access to Care Act of 2021 Sponsor: Rep. Suzan DelBene (D-WA-01) S. 3018 - Improving Seniors Timely Access to Care Act of 2021 Sponsor: Sen. Roger Marshall (R-KS) H.R. 8594 - Restore Protections for Dialysis Patients Act To amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act. Sponsor: Rep. Yvette Clarke (D-NY-09) S. 4750 - Restore Protections for Dialysis Patients Act A bill to amend title XVIII of the Social Security Act to clarify and preserve the breadth of the protections under the Medicare Secondary Payer Act. Sponsor: Sen. Bob Menendez (D-NJ)
Client expense: $1,370,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
2022 · fourth_quarter · Medicare/Medicaid
Issues and legislation relating to kidney disease. Policies that impact kidney care providers and patients. 2022 Labor, HHS, Education and Related Agencies Appropriations bill (KidneyX Program) S.1971 and H.R.4065 - Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 S.377 and H.R.1255 - Living Donor Protection Act of 2021 S. 4750 and H.R. 8594 Restore Protections for Dialysis Patients Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2022 · fourth_quarter · Small Business
House Bills H.R. 842, the Protecting the Right to Organize (PRO) Act of 2021 - oppose. H.R. 1381, the Main Street Tax Certainty Act - support. H.R. 3185, the Save Local Business Act - support. Sec. 804 of H.R. 4350, the National Defense Authorization Act for Fiscal Year 2023, Minimum Wage for Employees of Department of Defense Contractors - oppose. H.R. 6161, the Employee Retention Tax Credit Reinstatement Act. - support. H.R. 1284, the Fair and Open Competition Act - support. H.R. 5743, the Ensuring Workers Get PAID Act of 2021 - support. H.R. 3425, the Saving Gig Economy Taxpayers Act - support. H.R. 6913, the Stop the Nosy Obsession with Online Payments Act (SNOOP Act) of 2022 - support. H.R. 8152, the American Data Privacy and Protection Act - oppose. H.R. 7701, the Wage Theft Prevention and Recovery Act - oppose. H.R. 6833, the Affordable Insulin Now Act - express concern. H.R. 7505, the American Innovation and Choice Online Act of 2022 - support. H.R. 8874, the Credit Card Competition Act of 2022 - support. Schakowsky amendment #3 to H.R. 7900, the National Defense Authorization Act for Fiscal Year 2023 - oppose. H.R. 8594, the Restore Protections for Dialysis Patients Act (RPDPA) - oppose. H.R. 9092, the Family and Small Business Taxpayer Protection Act - support. Senate Bills S. 53, the Raise the Wage Act of 2021 - oppose. S. 480, the Main Street Tax Certainty Act - support. S. 420, the Protecting the Right to Organize (PRO) Act of 2021 - oppose. S. 1636, the Save Local Business Act - support. S. 2239, the Unnecessary Agency Regulations Reduction Act of 2021 - support. S. 403, the Fair and Open Competition Act - support. S. 3074, the Ensuring Workers Get PAID Act of 2021 - support. S. 3889, the Employee Rights Act - support S. 3625, the Employee Retention Tax Credit Reinstatement Act - support S. 3546, the Stop the Nosy Obsession with Online Payments Act (SNOOP Act) of 2022 - support. The Improving Needed Safeguards for Users of Lifesaving Insulin Now (INSULIN Act) - express concern. S. 2992, the American Innovation and Choice Online Act - support. S. 4293, the Pharmacy Benefit Manager Transparency Act of 2022 - support. ENABLERS Act amendment to National Defense Authorization Act - oppose. S. 4674, the Credit Card Competition Act of 2022 - support. S. 4750/H.R. 8594, the Restore Protections for Dialysis Patients Act (RPDPA) - oppose. Braun and Hassan Amendment - FDA User Fee Reauthorization - small business user fee waiver - support. Other Issues Transparency in operations of Pharmacy Benefit Managers (PBMs) - support. Revision of the Navigable Waters Protection Rule (NWPR) - oppose. Government-mandated Project Labor Agreements - oppose. Comments Department of Labor Wage and Hour Division Notice of Proposed Rulemaking titled Employee or Independent Contractor Classification Under the Fair Labor Standards Act, RIN1235-AA43, 87 Fed. Reg. 62218 (Oct 13, 2022) Comments on NLRB Notice of Proposed Rulemaking titled Standard for Determining Joint-Employer Status, RIN 3142-AA21, 87 Fed. Reg. 54641(Sept 7, 2022), 87 Fed. Reg. 63465 (Oct 19, 2022)
Client expense: $945,000 · Firm income: Not reported
Government targets: Environmental Protection Agency (EPA), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), Occupational Safety & Health Administration (OSHA), SENATE, Small Business Administration (SBA)
2022 · fourth_quarter · Health Issues
S. 4750, Restore Protections for Dialysis Patients Act, provisions related to commercial health coverage. H.R. 4587, Value in Health Care Act, provisions related to Accountable Care Organizations. S. 3018/H.R. 3173, Improving Seniors Timely Access to Care Act of 2021, provisions related to Medicare Advantage. Veterans Care Coordination, Health equity issues, COVID transition & the Public Health Emergency.
Client expense: $720,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE